Press release
Investigation announced for Long-Term Investors in shares of Eli Lilly and Company (NYSE: LLY)
An investigation on behalf of investors in Eli Lilly and Company (NYSE: LLY) shares over potential wrongdoing at Eli Lilly and Co.
Investors who purchased shares of Eli Lilly and Company (NYSE: LLY) a have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Eli Lilly and Company (NYSE: LLY officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
In August 2020, Eli Lilly and Company began a clinical trial to test whether adding the Company's antibody-based drug, LY-CoV555, to remdesivir would benefit patients diagnosed with COVID-19.
On October 13, 2020, the trial's sponsor, the National Institute of Allergy and Infectious Diseases ("NIAID") recommended that the trial be paused after an analysis of safety data found "an overall difference in clinical status between the group receiving LY-CoV555 and the group receiving saline placebo."
Shares of Eli Lilly and Company (NYSE: LLY) declined from $157.15 per share on October 9, 2020 to as low as $142.24 per share on October 19, 2020.
Those who purchased shares of Eli Lilly and Company (NYSE: LLY) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Eli Lilly and Company (NYSE: LLY) here
News-ID: 2184159 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for Eli
Healthcare BPO Market 2021 Overview - Eli Global, Gebbs, Genpact
Global “Healthcare BPO Market” 2021 Research report produces information with reference to market size, share, trends, growth, cost structure, capacity, revenue, and forecast 2027. This report also contains the general and comprehensive study of the Healthcare BPO market with all its aspects influencing the growth of the market. This report is a full-scale quantitative survey of the Healthcare BPO industry and provides data for building strategies to expand the market…
Brain Disease Market SWOT Analysis | Pfizer, Eli Lilly, GE Healthcare
A new research study from HTF MI with title Global Brain Disease Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2025 provides an in-depth assessment of the Brain Disease including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies. The research study provides forecasts for Brain Disease market till 2025.
Top Players: Pfizer Inc. (United States) , Eli Lilly (United States)…
Cannabis Testing Market by Top Key Players - Agilent Technologies, Perkin Elmer, …
Cannabis testing defines various drug test methods for the usage of cannabis in medical prescription, sports medicine, and law. The rapidly increasing applications of cannabis (marijuana) in mainstream medicine such as pain management is poised to increase demand for cannabis testing measures.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2872404?utm_source=RK&utm_medium=OPR
The Cannabis Testing Market research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and…
Eli Destroy Drops Wonderful Trap Single “Water Torture Cell”
Trap music has gained good popularity is the world of music. A lot of singers, who like experimenting with new genre of music, are recently working with trap music. Eli Destroy, the new trap music singer in soundcloud has come up with another new single. This artist is also known as Elijah Cook. People will live listening to his music in repeat. Even listeners who have no affinity for trap…
Insulin Pen Market 2017- Novo Nordisk , Eli Lilly , Sanofi
Insulin Pen Market is likely to reach more than US$ 12 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022.
Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human…
Global Raloxifene Hydrochloride Market 2017 - Eli Lilly, InvaGen Pharmaceuticals
The report entitled Global Raloxifene Hydrochloride Market 2017 presents key insights into the global Raloxifene Hydrochloride market along with the latest up-to-date industry details and forthcoming Raloxifene Hydrochloride industry trends, which will assist the readers to focus on product specification and end users driving the overall market revenue and profitability.
Report Keynotes:
The main motive of the report on "Global Raloxifene Hydrochloride Market 2017" is to study comprehensive details of the market…
